Trident Lifeline Ltd. (TLL): Trident Lifeline Share Price rises 12.68% as TLL closes at Rs 355
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Trident Lifeline Share Price rose to Rs 355 today, up 12.68% from the previous close of Rs 315.05, while the company’s market capitalisation stood at Rs 376.71 crore. The move places Trident Lifeline Ltd. in today’s stocks in news list, but the supplied data does not establish a company-specific catalyst. What it does confirm is a sharp same-day price rise, a close at the day’s high of Rs 355, and turnover of Rs 2.56 crore. For readers tracking Trident Lifeline Share Price Today, the event is relevant because it combines a clear price action move with compact valuation data, sector comparison and peer context. Univest is useful here because it brings the same-day move together with the broader stock story in one place.
The stock opened at Rs 322.55, touched a low of Rs 316.2 and finished at Rs 355. That sequence shows a steady intraday recovery into the close. Since no company-specific trigger is supplied, this Trident Lifeline Stock News note focuses on verified market data, Trident Lifeline Share Price Rise context and the financial ratios that help frame the move.
Trident Lifeline Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 355 |
| Previous Close | Rs 315.05 |
| Today's Move | Rs 39.95 (+12.68%) |
| Open | Rs 322.55 |
| High | Rs 355 |
| Low | Rs 316.2 |
| Turnover | Rs 2.56 crore |
| Market Capitalisation | Rs 376.71 crore |
| Market Cap Category | Micro Cap |
Trident Lifeline Ltd. (TLL) rose to Rs 355 from the previous close of Rs 315.05, a move of Rs 39.95 or 12.68%. The stock opened at Rs 322.55, reached a high of Rs 355, recorded a low of Rs 316.2.
Trident Lifeline Share Price Today rose Rs 39.95, or 12.68%, to Rs 355. The stock closed at the day’s high, compared with the previous close of Rs 315.05. The intraday range was Rs 316.2 to Rs 355, and the opening print was Rs 322.55. Turnover stood at Rs 2.56 crore. These numbers show the full same-day price move without adding any unverified explanation. For Trident Lifeline Share Price Live tracking, the key factual point is that the close matched the session high. That makes this a notable share price rise and a clear item for Trident Lifeline News Today and Trident Lifeline Share News coverage on Univest.
Trident Lifeline Ltd. (TLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 376.71 crore |
| P/E Ratio | 19.78x |
| P/B Ratio | 3.82x |
| ROE | 18.78% |
| ROCE | 19.17% |
| EPS | Rs 15.92 |
| Book Value Per Share | Rs 82.4 |
| Dividend Yield | 0% |
Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 19.78x, P/B 3.82x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.
Trident Lifeline Ltd. has a market capitalisation of Rs 376.71 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 19.78x, P/B at 3.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 19.78x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 3.82x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 18.78% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 19.17% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 376.71 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Trident Lifeline Ltd. (TLL) has a P/E ratio of 19.78x, which is below the benchmark median of 32.87x, a difference of -39.82%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.7%, a difference of +60.51%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.46%, a difference of +42.42%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Trident Lifeline Ltd. (TLL) has a P/E ratio of 19.78x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 376.71 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching TLL
- Trident Lifeline Share Price rose 12.68% today to Rs 355, and the close matched the intraday high.
- Previous close was Rs 315.05, which makes the day’s gain Rs 39.95 in a single session.
- Market capitalisation stood at Rs 376.71 crore, placing the company below the industry median market cap.
- P/E ratio of 19.78 is below the industry median of 32.87 and average of 48.77.
- ROE of 18.78% and ROCE of 19.17% both stand above the same-industry medians.
About Trident Lifeline
Trident Lifeline Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s listed data positions it within a broad healthcare peer group that includes large-cap and mid-sized pharmaceutical companies, but the supplied figures here focus on market valuation, profitability and scale rather than a detailed product mix. Based on the available financials, Trident Lifeline’s Trident Lifeline Share Price story is better understood through its earnings, book value and return metrics than through any unverified operating narrative.
The company’s P/E of 19.78, P/B of 3.82, ROE of 18.78%, ROCE of 19.17%, EPS of Rs 15.92 and book value of Rs 82.4 together provide a compact financial profile. Dividend yield is 0, so the current valuation context is not being shaped by a dividend yield component. For investors searching Trident Lifeline Stock News or Trident Lifeline Company News, the key point is that the business sits in a healthcare industry with clear benchmark data and a same-day price rise that merits monitoring on Univest.
Track Trident Lifeline Share Price on Univest
Use Trident Lifeline Ltd. (TLL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Trident Lifeline Share Price on Univest can be tracked alongside live share price updates, fundamental ratios, shareholding pattern, 52-week levels and broader market insights. Users can also follow Trident Lifeline Stock Analysis, Trident Lifeline Fundamental Analysis and Trident Lifeline Share Price Today in one place. Univest helps readers compare the move with sector peers and keep the same-day context organised without turning it into a recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Trident Lifeline Share Price rise today?
Ans. The supplied data confirms a 12.68% same-day rise to Rs 355, but it does not establish a company-specific catalyst. The move is factual, and the session closed at the day’s high.
What is Trident Lifeline Share Price Today?
Ans. Trident Lifeline Share Price Today is Rs 355. It rose Rs 39.95 from the previous close of Rs 315.05, and the day’s trading range stayed between Rs 316.2 and Rs 355.
What is Trident Lifeline market capitalisation?
Ans. Trident Lifeline’s market capitalisation is Rs 376.71 crore. That places the company below the same-industry median market cap of Rs 701.78 crore across 204 healthcare peers. The company operates in the Healthcare sector.
How does Trident Lifeline compare on valuation?
Ans. Trident Lifeline Share Price is supported by a P/E of 19.78 and a P/B of 3.82. Its P/E sits below the industry median of 32.87, while P/B is above the median of 3.08.
What do Trident Lifeline earnings metrics show?
Ans. EPS is Rs 15.92, ROE is 18.78% and ROCE is 19.17%. These figures show positive earnings per share and return ratios above the industry medians in the same sector benchmark.
Does Trident Lifeline pay a dividend?
Ans. The supplied dividend yield is 0, so the current data does not show a dividend yield component. Investors usually look at this alongside price action, book value and profitability ratios.
How does Trident Lifeline compare with sector peers?
Ans. Trident Lifeline is much smaller than Sun Pharma, Divi’s Labs, Torrent Pharma, Zydus Lifesciences and Cipla by market cap. Its P/E is lower than all five peers listed here. The stock belongs to the Healthcare sector.
